HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease

Published:2017-01 Issue:2 Volume:69 Page:246-247
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bauer Lucie,Kern Sabine,Rogacev Kyrill S.,Emrich Insa E.,Zawada Adam,Fliser Danilo,Heinemann Akos,Heine Gunnar H.,Marsche Gunther

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis;Khera;N Engl J Med,2011

2. HDL cholesterol efflux capacity and incident cardiovascular events;Rohatgi;N Engl J Med,2014

3. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study;Saleheen;Lancet Diabetes Endocrinol,2015

4. HDL cholesterol efflux does not predict cardiovascular risk in hemodialysis patients;Kopecky;J Am Soc Nephrol,2016

5. Inflammation alters HDL composition and function: implications for HDL-raising therapies;Marsche;Pharmacol Ther,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKD;Journal of Lipid Research;2024-09

2. Lipoprotein dysfunction in patients with chronic kidney disease (CKD). Pathogenesis and treatment of CKD dyslipidemia (literature review);Nephrology (Saint-Petersburg);2024-03-03

3. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients;Journal of Lipid Research;2023-06

4. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy;Circulation Research;2023-05-26

5. A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease;Pharmaceutics;2023-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3